Avicanna inks agreement with Chilean pharma Knop Laboratorios to supply range of cannabinoid-based API
Avicanna Inc., a biopharmaceutical company, announced that through its majority owned subsidiary Santa Marta Golden Hemp (SMGH) the company has entered into a Master Supply Agreement with established Chilean pharmaceutical company Knop Laboratorios S.A. (Knop) to supply a range of cannabinoid-based active pharmaceutical ingredients (API) for the manufacturing, and commercialization of proprietary cannabinoid-based pharmaceutical products in Latin America. Since 2018, Avicanna and Knop have developed a collaborative enterprise which has led to commercial imports of Avicanna
Optimize Your trial insights with Clival Database.
Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.
With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.
To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.
Elevate your trial success rate with the cutting-edge insights from Clival database.
Check it out today and make more informed sourcing decisions! Learn More!
